VEGFA and proliferative diabetic retinopathy: This went against the conclusion from the review “Anti-endothelial vascular growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy”, which was a review with high-quality evidence.